Other languages Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Delayed NSE India S.E. Other stock markets 03:50:56 28/05/2024 pm IST			5-day change	1st Jan Change
446.8 ^INR	+1.27%		-1.47%	+3.85%

15/05	Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	RE
25/04	Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion	15/05
Laurus Labs' Consolidated Profit Falls in Fiscal Q4	25/04
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024	25/04
Laurus Labs Limited Approves Board Changes	25/04
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024	25/04
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	25/04
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%	26/01
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd	25/01
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	24/01
INDIA STOCKS-IT drives losses in Indian shares ahead of Fed policy outcome	13/12
Indian shares set to open higher; focus turns to Fed policy	13/12
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio	21/11
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.	20/11
Laurus Labs Limited Announces Resignation of Chandrakanth Chereddi as Non-Executive Director	20/23/20
Laurus Labs Limited Approves Interim Dividend, Payable on or After November 09, 2023	20/23/20
Laurus Labs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	20/23/20
India's Divi's Labs Q1 profit slumps on drug pricing pressures	14/23/14
Laurus Labs' Consolidated Profit Tanks in Fiscal Q1; Shares Climb 4%	31/23/31
Laurus Labs Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	27/23/27
Laurus Labs Pays First Tranche to Acquire Additional Stake in Cell and Gene Therapy Company	13/23/13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Other languages

Filters